BridgeMD
New treatment option for Hip Fracture
Official title Remote Ischaemic Conditioning for Post-surgical Complications in Hip Fracture (RIC-FRACTURE)
ClinicalTrials.gov ID: NCT07178041
What this study is testing
- What it's testing
- Background Hip fracture affects 70,000 people in the United Kingdom (UK) and costs an estimated £1.1 billion per year to the National Health Service (NHS). Key clinical indicators, such as early surgical repair, have been shown to improve patient outcomes, however morbidity and mortality remain extremely high, reflecting the urgent need for novel therapies to enhance outcomes.
- Time commitment: about 2 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (aged \> 18 years)
- Participant has had a hip fracture identified on X-ray or computed tomography (CT) scan.
- Qualifying hip fracture has not occurred more than 7 days prior to enrollment.
- Able to give written informed consent.
- In the opinion of the treating physician would be able to conform to the study protocol and procedures.
You likely can't join if
- History or presence of significant peripheral vascular disease in the limb conditioned.
- History or presence of complex neuropathic pains or peripheral neuropathy in the limb conditioned.
- Presence of lymphoedema in the limb conditioned.
- Presence of skin ulceration to the limb conditioned.
- Uncontrolled arrhythmia, hypertension, diabetes or angina.
- Third degree heart block or progressive heart failure.
See the full eligibility criteria
- Adults (aged \> 18 years)
- Participant has had a hip fracture identified on X-ray or computed tomography (CT) scan.
- Qualifying hip fracture has not occurred more than 7 days prior to enrollment.
- Able to give written informed consent.
- In the opinion of the treating physician would be able to conform to the study protocol and procedures.
- History or presence of significant peripheral vascular disease in the limb conditioned.
- History or presence of complex neuropathic pains or peripheral neuropathy in the limb conditioned.
- Presence of lymphoedema in the limb conditioned.
- Presence of skin ulceration to the limb conditioned.
- Uncontrolled arrhythmia, hypertension, diabetes or angina.
- Third degree heart block or progressive heart failure.
- Acute aortic dissection, myocarditis, or pericarditis.
- Acute deep vein thrombosis, pulmonary embolism.
- Suspected or known dissecting aneurysm.
- Stroke or TIA myocardial infarction in the last 4 weeks.
The study team makes the final eligibility decision.
Where it's taking place
- Sheffield, South Yorkshire, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sheffield, South Yorkshire, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.